Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network-Reference-Cited by-同舟云学术

Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network

Published:2024-08-22 Issue: Volume: Page:
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Faron M.^ORCID,Naman A.,Delahousse J.,Hescot S.,Hadoux J.,Castinetti F.,Drui D.,Renoult-Pierre P.,Libe R.,Lamartina L.,Leboulleux S.,Al-Ghuzlan A.,Lombès M.,Paci A.,Baudin E.,

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40618-024-02439-7.pdf

Reference37 articles.

1. Libé R, Borget I, Ronchi CL et al (2015) Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann Oncol Off J Eur Soc Med Oncol 26:2119–2125. https://doi.org/10.1093/annonc/mdv329

2. Fassnacht M, Assie G, Baudin E et al (2020) Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 31:1476–1490. https://doi.org/10.1016/j.annonc.2020.08.2099

3. Naing A, Meric-Bernstam F, Stephen B et al (2020) Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer 8:e000347. https://doi.org/10.1136/jitc-2019-000347

4. Fassnacht M, Dekkers O, Else T et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. https://doi.org/10.1530/EJE-18-0608

5. Haak HR, Hermans J, Velde CJ et al (1994) Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 69:947–951. https://doi.org/10.1038/bjc.1994.183